Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -248,497 | -210,752 | -131,325 | -80,824 | -35,816 |
| Depreciation Amortization | 2,455 | 712 | 1,477 | 1,453 | 439 |
| Accounts payable and accrued liabilities | 6,200 | 2,688 | 2,315 | -994 | 1,072 |
| Other Working Capital | 13,079 | 8,180 | 13,524 | 10,116 | -6,470 |
| Other Operating Activity | 31,355 | 30,044 | 14,404 | 13,635 | 5,085 |
| Operating Cash Flow | $-195,408 | $-169,128 | $-99,605 | $-56,614 | $-35,690 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,047 | -9,420 | -6,425 | -7,665 | -1,708 |
| Purchase Of Investment | -166,321 | -261,293 | -129,534 | -197,178 | -152,811 |
| Sale Of Investment | 286,267 | 174,703 | 178,521 | 160,947 | 29,250 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 40 |
| Investing Cash Flow | $111,899 | $-96,010 | $42,562 | $-43,896 | $-125,229 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -3,856 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 288,435 | 6,520 | 145,000 | 168,119 |
| Other Financing Activity | 19,734 | 10,727 | 0 | 2,843 | 67,208 |
| Financing Cash Flow | $55,878 | $299,162 | $6,520 | $147,843 | $235,327 |
| Beginning Cash Position | 107,511 | 73,487 | 124,010 | 76,677 | 2,269 |
| End Cash Position | 79,880 | 107,511 | 73,487 | 124,010 | 76,677 |
| Net Cash Flow | $-27,631 | $34,024 | $-50,523 | $47,333 | $74,408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -195,408 | -169,128 | -99,605 | -56,614 | -35,690 |
| Capital Expenditure | -8,047 | -9,420 | -6,425 | -7,665 | -1,708 |
| Free Cash Flow | -203,455 | -178,548 | -106,030 | -64,279 | -37,398 |